Global and China Gastrointestinal Therapeutics Market Size, Status and Forecast 2020-2026

Global and China Gastrointestinal Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 IBD
1.3.3 Irritable Bowel Syndrome (IBS)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics Market Perspective (2015-2026)
2.2 Global Gastrointestinal Therapeutics Growth Trends by Regions
2.2.1 Gastrointestinal Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastrointestinal Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics Players by Market Size
3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
3.4 Global Gastrointestinal Therapeutics Market Concentration Ratio
3.4.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2019
3.5 Key Players Gastrointestinal Therapeutics Area Served
3.6 Key Players Gastrointestinal Therapeutics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2021-2026)
5 Gastrointestinal Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gastrointestinal Therapeutics Market Size (2015-2026)
6.2 North America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
6.3 North America Gastrointestinal Therapeutics Market Size by Application (2015-2020)
6.4 North America Gastrointestinal Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size (2015-2026)
7.2 Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020)
7.3 Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020)
7.4 Europe Gastrointestinal Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Gastrointestinal Therapeutics Market Size (2015-2026)
8.2 China Gastrointestinal Therapeutics Market Size by Type (2015-2020)
8.3 China Gastrointestinal Therapeutics Market Size by Application (2015-2020)
8.4 China Gastrointestinal Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Gastrointestinal Therapeutics Market Size (2015-2026)
9.2 Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020)
9.3 Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020)
9.4 Japan Gastrointestinal Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Gastrointestinal Therapeutics Introduction
11.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020))
11.1.5 AbbVie Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Gastrointestinal Therapeutics Introduction
11.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020)
11.2.5 Allergan Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020)
11.3.5 Johnson & Johnson Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Gastrointestinal Therapeutics Introduction
11.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
11.4.5 Takeda Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Gastrointestinal Therapeutics Introduction
11.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Gastrointestinal Therapeutics Introduction
11.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020)
11.6.5 Pfizer Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Gastrointestinal Therapeutics Introduction
11.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020)
11.7.5 Merck Recent Development
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Details
11.8.2 F. Hoffmann-La Roche Business Overview
11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
11.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020)
11.8.5 F. Hoffmann-La Roche Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
11.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020)
11.9.5 Eli Lilly Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
11.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020)
11.10.5 AstraZeneca Recent Development
11.11 Procter & Gamble
10.11.1 Procter & Gamble Company Details
10.11.2 Procter & Gamble Business Overview
10.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
10.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.11.5 Procter & Gamble Recent Development
11.12 Tillotts Pharma
10.12.1 Tillotts Pharma Company Details
10.12.2 Tillotts Pharma Business Overview
10.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
10.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.12.5 Tillotts Pharma Recent Development
11.13 Takeda
10.13.1 Takeda Company Details
10.13.2 Takeda Business Overview
10.13.3 Takeda Gastrointestinal Therapeutics Introduction
10.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.13.5 Takeda Recent Development
11.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Company Details
10.14.2 GlaxoSmithKline Business Overview
10.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
10.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.14.5 GlaxoSmithKline Recent Development
11.15 Amgen
10.15.1 Amgen Company Details
10.15.2 Amgen Business Overview
10.15.3 Amgen Gastrointestinal Therapeutics Introduction
10.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.15.5 Amgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Oral
Table 4. Key Players of Parenteral
Table 5. Global Gastrointestinal Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Gastrointestinal Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Gastrointestinal Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Gastrointestinal Therapeutics Market Share by Regions (2015-2020)
Table 9. Global Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Gastrointestinal Therapeutics Market Share by Regions (2021-2026)
Table 11. Gastrointestinal Therapeutics Market Market Trends
Table 12. Gastrointestinal Therapeutics Market Drivers
Table 13. Gastrointestinal Therapeutics Market Challenges
Table 14. Gastrointestinal Therapeutics Market Restraints
Table 15. Global Gastrointestinal Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Gastrointestinal Therapeutics Market Share by Players (2015-2020)
Table 17. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics as of 2019)
Table 18. Global Gastrointestinal Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gastrointestinal Therapeutics Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Gastrointestinal Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Gastrointestinal Therapeutics Market Size Share by Type (2015-2020)
Table 24. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2021-2026)
Table 25. Global Gastrointestinal Therapeutics Market Size Share by Application (2015-2020)
Table 26. Global Gastrointestinal Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Gastrointestinal Therapeutics Market Size Share by Application (2021-2026)
Table 28. North America Gastrointestinal Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 30. North America Gastrointestinal Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 32. North America Gastrointestinal Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Gastrointestinal Therapeutics Market Share by Country (2015-2020)
Table 34. Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 36. Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Gastrointestinal Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Gastrointestinal Therapeutics Market Share by Country (2015-2020)
Table 40. China Gastrointestinal Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 41. China Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 42. China Gastrointestinal Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 43. China Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 44. China Gastrointestinal Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 45. China Gastrointestinal Therapeutics Market Share by Region (2015-2020)
Table 46. Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 48. Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Gastrointestinal Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Gastrointestinal Therapeutics Market Share by Country (2015-2020)
Table 52. Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Gastrointestinal Therapeutics Market Share by Type (2015-2020)
Table 54. Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Gastrointestinal Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Gastrointestinal Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Gastrointestinal Therapeutics Market Share by Country (2015-2020)
Table 58. AbbVie Company Details
Table 59. AbbVie Business Overview
Table 60. AbbVie Product
Table 61. AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 62. AbbVie Recent Development
Table 63. Allergan Company Details
Table 64. Allergan Business Overview
Table 65. Allergan Product
Table 66. Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 67. Allergan Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Product
Table 71. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Takeda Company Details
Table 74. Takeda Business Overview
Table 75. Takeda Product
Table 76. Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 77. Takeda Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Product
Table 81. Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 82. Novartis Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Product
Table 86. Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Product
Table 91. Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 92. Merck Recent Development
Table 93. F. Hoffmann-La Roche Business Overview
Table 94. F. Hoffmann-La Roche Product
Table 95. F. Hoffmann-La Roche Company Details
Table 96. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 97. F. Hoffmann-La Roche Recent Development
Table 98. Eli Lilly Company Details
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Product
Table 101. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 102. Eli Lilly Recent Development
Table 103. AstraZeneca Company Details
Table 104. AstraZeneca Business Overview
Table 105. AstraZeneca Product
Table 106. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 107. AstraZeneca Recent Development
Table 108. Procter & Gamble Company Details
Table 109. Procter & Gamble Business Overview
Table 110. Procter & Gamble Product
Table 111. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 112. Procter & Gamble Recent Development
Table 113. Tillotts Pharma Company Details
Table 114. Tillotts Pharma Business Overview
Table 115. Tillotts Pharma Product
Table 116. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 117. Tillotts Pharma Recent Development
Table 118. Takeda Company Details
Table 119. Takeda Business Overview
Table 120. Takeda Product
Table 121. Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 122. Takeda Recent Development
Table 123. GlaxoSmithKline Company Details
Table 124. GlaxoSmithKline Business Overview
Table 125. GlaxoSmithKline Product
Table 126. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 127. GlaxoSmithKline Recent Development
Table 128. Amgen Company Details
Table 129. Amgen Business Overview
Table 130. Amgen Product
Table 131. Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020) (US$ Million)
Table 132. Amgen Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. IBD Case Studies
Figure 6. Irritable Bowel Syndrome (IBS) Case Studies
Figure 7. Gastrointestinal Therapeutics Report Years Considered
Figure 8. Global Gastrointestinal Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 9. Global Gastrointestinal Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Gastrointestinal Therapeutics Market Share by Regions (2021-2026)
Figure 11. Global Gastrointestinal Therapeutics Market Share by Players in 2019
Figure 12. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Therapeutics as of 2019
Figure 13. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2019
Figure 14. North America Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 15. United States Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. Canada Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Europe Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Germany Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. France Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. U.K. Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Italy Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Russia Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Nordic Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Rest of Europe Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Asia-Pacific Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. China Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. South Korea Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. India Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Australia Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Asia-Pacific Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Latin America Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Mexico Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Brazil Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Middle East & Africa Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Turkey Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Saudi Arabia Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. UAE Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Middle East & Africa Gastrointestinal Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 42. Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 43. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 44. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 45. Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 46. Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 47. Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 49. Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 50. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 51. Procter & Gamble Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 52. Tillotts Pharma Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 53. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 55. Amgen Revenue Growth Rate in Gastrointestinal Therapeutics Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs